JIN YANG PHARMACEUTICAL (007370) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, JIN YANG PHARMACEUTICAL (007370) reported revenue of 120.7 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
2025120.7 billion KRW2.5 billion KRW22.3 billion KRW[source]
2024113.3 billion KRW11.7 billion KRW29.7 billion KRW[source]
202394.1 billion KRW9.1 billion KRW12.7 billion KRW[source]
202276.3 billion KRW11.1 billion KRW12.3 billion KRW[source]
202162.8 billion KRW7.0 billion KRW9.5 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025267.8 billion KRW108.0 billion KRW159.9 billion KRW[source]
2024227.6 billion KRW107.7 billion KRW119.9 billion KRW[source]
2023119.9 billion KRW30.3 billion KRW89.6 billion KRW[source]
2022114.4 billion KRW36.9 billion KRW77.6 billion KRW[source]
202198.5 billion KRW33.2 billion KRW65.3 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice